News
Pharmacotherapy in post-stroke rehabilitation
28.06.2022
The article presents data on the conditions of use and efficacy of botulinum toxin preparations, oral muscle relaxants, selective serotonin reuptake inhibitors, acetylcholinesterase inhibitors and a glutamatergic transmission modulator in post-stroke neurorehabilitation, and provides recommendations for their rational and safe use.
Use of Mexidol in the Therapy of Primary Open-angle Glaucoma
09.06.2022
The article focuses on the complex therapy of primary open-angle glaucoma, namely the application and understanding of the principles of neuroprotection in the pathogenesis of the development of glaucomatosis optic neuropathy.
Efficacy of Mexidol in patients with type 2 diabetes mellitus with neurological complications
01.06.2022
Objective. Complications of Diabetes mellitus (DM), depends on the severity of hypoxic tissue damage. Amelioration of hypoxic injury may improve current therapy approaches and enhance the quality of life in patient’s cohort suffered from DM.